Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
Clinical trial NCT01334502 · COMPLETED
Trial details
- NCT number
- NCT01334502
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.